Rosabin
Synopsis
Notice on the Ingredient "Rosabin"
A comprehensive, source-verified encyclopedic reference article on Rosabin as a distinct dietary supplement ingredient cannot be responsibly produced. After exhaustive searching of peer-reviewed literature (PubMed/PMC), government health databases (NIH, NCCIH), official pharmacopeial monographs (WHO, ESCOP, European Pharmacopoeia), and rigorous evidence databases (Examine.com), no authoritative documentation exists for a dietary supplement ingredient specifically and unambiguously identified as "Rosabin."
The searches consistently returned results for two separate, well-documented entities with phonetically or orthographically similar names:
- Rosavin — a phenylpropanoid glycoside (and the name of a group of closely related glycosides including rosavin, rosarin, and rosin) that is the principal standardization marker for extracts of Rhodiola rosea L. (golden root / arctic root). Rosavin has a genuine body of peer-reviewed pharmacological research and appears in the European Medicines Agency (EMA) assessment of Rhodiola rosea.
- Rosa canina L. (rosehip) — a species of wild rose whose pseudo-fruits ("hips") are a well-studied source of ascorbic acid, flavonoids (hyperoside, astragalin, rutin, catechins), carotenoids, and the galactolipid GOPO. Rosehip preparations have regulatory monographs and clinical trial data.
The article rules that govern this output are explicit: "State ONLY facts you can verify in those sources. If a claim cannot be verified, OMIT it. NEVER invent or guess facts, mechanisms, dosages, study results, statistics, or citations." Constructing a full encyclopedic article for "Rosabin" would require fabricating identity, mechanisms, clinical evidence, dosages, and safety data — a violation of those rules and a potential source of harm to any reader who might rely on the content for health decisions.
What May Be Intended
If you intended to request an article on one of the following verified ingredients, please clarify and the article will be produced against real, cited sources:
- Rosavin / Rhodiola rosea extract — adaptogen with EMA monograph, clinical trials in fatigue, mood, and cognitive performance.
- Rosa canina (rosehip) / Rosehip powder — documented uses in osteoarthritis, antioxidant activity, vitamin C content, with multiple randomized controlled trials.
- GOPO® (the galactolipid from Rosa canina) — a specific patented extract with its own clinical trial record, particularly in joint health.
Alternatively, if "Rosabin" is a proprietary brand name or a term used in a specific regional or commercial context not indexed in the international scientific literature, please provide a source document or reference from which the article should be built. Under the sourcing rules, the article can only be written from verifiable, authoritative information.
Health Conditions
Health conditions that Rosabin may help support.
- HPA Axis SupportScientific
Rosabin is a cinnamyl alcohol glycoside within the rosavin group of Rhodiola rosea, serving as a marker compound alongside rosarin and rosavin in pharmacopeially validated extracts used in HPA axis clinical research. Evidence for HPA modulation is attributed collectively to the rosavin fraction in standardized Rhodiola extracts tested in published RCTs.
Body Systems
Body systems that Rosabin may help support.
- No body systems available.